Source: PLOS ONE. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, ANDRÓGENOS, ANTINEOPLÁSICOS, QUALIDADE DE VIDA
ABNT
BOTREL, Tobias Engel Ayer et al. Efficacy and safety of combined androgen deprivation therapy (ADT) and docetaxel compared with ADT alone for metastatic hormone-naive prostate cancer: a systematic review and meta-analysis. PLOS ONE, v. 11, n. 6, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0157660. Acesso em: 03 jun. 2024.APA
Botrel, T. E. A., Clarck, O., Pompeo, A. C. L., Bretas, F. F. H., Sadi, M. V., Ferreira, U., & Reis, R. B. dos. (2016). Efficacy and safety of combined androgen deprivation therapy (ADT) and docetaxel compared with ADT alone for metastatic hormone-naive prostate cancer: a systematic review and meta-analysis. PLOS ONE, 11( 6). doi:10.1371/journal.pone.0157660NLM
Botrel TEA, Clarck O, Pompeo ACL, Bretas FFH, Sadi MV, Ferreira U, Reis RB dos. Efficacy and safety of combined androgen deprivation therapy (ADT) and docetaxel compared with ADT alone for metastatic hormone-naive prostate cancer: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 6):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1371/journal.pone.0157660Vancouver
Botrel TEA, Clarck O, Pompeo ACL, Bretas FFH, Sadi MV, Ferreira U, Reis RB dos. Efficacy and safety of combined androgen deprivation therapy (ADT) and docetaxel compared with ADT alone for metastatic hormone-naive prostate cancer: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 6):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1371/journal.pone.0157660